Moxetumomab pasudotox: A first-in-class treatment for hairy cell leukemia
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Moxetumomab pasudotox: A first-in-class treatment for hairy cell leukemia
Authors
Keywords
-
Journal
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
Volume -, Issue -, Pages 107815521983804
Publisher
SAGE Publications
Online
2019-03-28
DOI
10.1177/1078155219838041
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
- (2018) Robert J. Kreitman et al. LEUKEMIA
- Chemoimmunotherapy for hairy cell leukemia
- (2015) Farhad Ravandi BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Long-term follow-up after purine analogue therapy in hairy cell leukaemia
- (2015) Monica Else et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- BRAF inhibitor therapy in HCL
- (2015) Sascha Dietrich et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Hairy cell leukemia
- (2015) Claire Dearden BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Immunoconjugates in the management of hairy cell leukemia
- (2015) Robert J. Kreitman et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Hairy cell leukemia: Past, present and future
- (2015) Bartlomiej M. Getta et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Potential breakthroughs with investigational drugs for hairy cell leukemia
- (2015) Tadeusz Robak et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Novel therapeutic options for relapsed hairy cell leukemia
- (2015) Preetesh Jain et al. LEUKEMIA & LYMPHOMA
- Hairy cell leukemia: Update on molecular profiling and therapeutic advances
- (2014) Michael R. Grever et al. BLOOD REVIEWS
- Update on the Biology and Treatment Options for Hairy Cell Leukemia
- (2014) Preetesh Jain et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Phase I Trial of Anti-CD22 Recombinant Immunotoxin Moxetumomab Pasudotox (CAT-8015 or HA22) in Patients With Hairy Cell Leukemia
- (2012) Robert J. Kreitman et al. JOURNAL OF CLINICAL ONCOLOGY
- Antibody Fusion Proteins: Anti-CD22 Recombinant Immunotoxin Moxetumomab Pasudotox
- (2011) R. J. Kreitman et al. CLINICAL CANCER RESEARCH
- Implications of minimal residual disease in hairy cell leukemia after cladribine using immunohistochemistry and immunophenotyping
- (2011) Martin S. Tallman LEUKEMIA & LYMPHOMA
- Hairy cell leukemia
- (2010) Pier Luigi Zinzani et al. CANCER
- Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis
- (2009) Monica Else et al. BRITISH JOURNAL OF HAEMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More